SCHEMBL150490

SCHEMBL150490

CC(c1c[nH]cn1)[C@H](N)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7052027 1.00 SLC7A5 (0.38) SLC7A5
SCHEMBL9488170 1.00 SLC7A5 (0.38) SLC7A5
Hydrochloric Acid SCHEMBL9789200 0.98 SLC7A5 (0.36) SLC7A5
SCHEMBL2513127 0.89 SLC7A5 (0.30) SLC7A5
SCHEMBL9489841 0.82
SCHEMBL27765896 0.82 CPB2 (0.31)
SCHEMBL9789201 0.82
SCHEMBL679593 0.81 SLC7A5 (0.33) SLC7A5
SCHEMBL5283576 0.81 SLC7A5 (0.33) SLC7A5
Hydrochloric Acid SCHEMBL9789372 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 776 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
CN-119882373-A IC carrier plate film removing agent and preparation and use methods thereof 昆山市板明电子科技有限公司 2025-04-25 CN claimed
EP-3555615-B9 MASS SPECTROMETRY ASSAY METHOD FOR DETECTION AND QUANTITATION OF KIDNEY FUNCTION METABOLITES METABOLON INC (US) 2025-03-19 EP claimed
WO-2025054293-A1 BIOMARKER FOR PROSTATE CANCER NATIONAL TAIWAN UNIVERSITY (TW) 2025-03-13 WO claimed
US-20250076301-A1 BIOMARKER FOR PROSTATE CANCER NATIONAL TAIWAN UNIVERSITY (TW) 2025-03-06 US claimed
WO-2025026869-A1 METHOD FOR SEPARATING EXTRACELLULAR VESICLES EXIT071 B.V. (NL) 2025-02-06 WO claimed
WO-2025019764-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS MATTERWORKS INC (US) 2025-01-23 WO claimed
WO-2025007066-A1 BIOMARKERS AND METHODS RELATED TO FRAGILE X SYNDROME UNIVERSITY OF MASSACHUSETTS (US) 2025-01-02 WO claimed
EP-3555615-B1 MASS SPECTROMETRY ASSAY METHOD FOR DETECTION AND QUANTITATION OF KIDNEY FUNCTION METABOLITES METABOLON INC (US) 2024-10-30 EP claimed
EP-4437319-A1 METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION Matterworks Inc (US) 2024-10-02 EP claimed
US-6146847-A INTRODUCING FOREIGN DNA INTO CELL; CONTACTING BEFORE, DURING, OR AFTER WITH BIOCOMPATIBLE EXPRESSION ENHANCING AGENT WHICH IS NOT BUTYRATE OR BUTYRIC ACID; MAINTAINING IN NON-SELECTIVE MEDIUM; AFTER 5 DAYS, DETECTING FOREIGN PROTEIN GENESPAN CORPORATION (US) 2000-11-14 US claimed
EP-1029073-A1 METHOD AND AGENT FOR DETERMINING AN ENZYMATIC ACTIVITY SUCH AS DEAMINASE BIO MERIEUX (FR) 2000-08-23 EP claimed
WO-1999064578-A1 STABILIZED TRANSIENT GENE EXPRESSION GENESPAN CORPORATION (US) 1999-12-16 WO claimed
CN-1238807-A Stabilized transient gene expression GENESPAN CORP (US) 1999-12-15 CN claimed
EP-0941356-A2 STABILIZED TRANSIENT GENE EXPRESSION Genespan Corporation (US) 1999-09-15 EP claimed
WO-1999024604-A1 METHOD AND AGENT FOR DETERMINING AN ENZYMATIC ACTIVITY SUCH AS DEAMINASE BIO MERIEUX (FR) 1999-05-20 WO claimed
WO-1998020146-A2 STABILIZED TRANSIENT GENE EXPRESSION GENESPAN CORPORATION (US) 1998-05-14 WO claimed
EP-0436611-A4 COMPOUND AND METHOD FOR THE RETARDATION OF COLLAGEN CROSS-LINKING 1992-03-11 EP claimed
EP-0436611-A1 COMPOUND AND METHOD FOR THE RETARDATION OF COLLAGEN CROSS-LINKING COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 1991-07-17 EP claimed
WO-1990006102-A1 COMPOUND AND METHOD FOR THE RETARDATION OF COLLAGEN CROSS-LINKING PEPTIDE TECHNOLOGY LIMITED (AU) 1990-06-14 WO claimed